Olfr694 Inhibitors
Olfr694, also known as Olfactory Receptor Family 2 Subfamily AG Member 1B, is a vital component of the olfactory system in Mus musculus (house mouse). As a member of the olfactory receptor family, Olfr694 is responsible for the detection and initiation of responses to odorant molecules in the nasal passages. This critical function is mediated through the recognition of odorants and the subsequent transduction of signals via G-protein-coupled receptor (GPCR) pathways. Similar to other olfactory receptors, Olfr694 features a 7-transmembrane domain structure, reflecting its evolutionary relationship with neurotransmitter and hormone receptors involved in cellular signaling. Inhibition of Olfr694 poses unique challenges, primarily due to the receptor's primary role in signal transduction rather than traditional enzymatic or structural functions. Therefore, the chemical inhibition of Olfr694 typically involves indirect mechanisms that target the intricate intracellular signaling pathways associated with olfaction. Various chemicals can impact Olfr694 indirectly by influencing pathways such as cAMP, cGMP, PKA, MEK/ERK, p38 MAPK, JAK2, AKT, PLC-IP3, NF-κB, and GPCR desensitization. These chemicals modulate these pathways, disrupting downstream events required for proper olfactory receptor gene expression and function.
In summary, Olfr694 plays a pivotal role in the mouse's ability to perceive and discriminate odors, and its inhibition involves the intricate modulation of signaling pathways associated with olfaction. While direct chemical inhibitors may be elusive, understanding the potential indirect inhibitors and their effects on olfactory pathways contributes to our comprehension of sensory biology. Further research and experimental validation are necessary to elucidate the precise mechanisms of Olfr694 inhibition and their implications in the field of olfaction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits the MEK/ERK pathway, indirectly affecting Olfr694. By blocking this pathway, it disrupts the downstream signaling events that regulate olfactory receptor gene expression, leading to inhibition of Olfr694. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 is a specific inhibitor of p38 MAPK, which plays a role in olfactory receptor signaling. By inhibiting p38 MAPK, this chemical indirectly affects Olfr694 by interfering with the downstream processes involved in olfactory signal transduction. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 inhibits JAK2, which is involved in olfactory receptor signaling. By blocking JAK2, this chemical indirectly influences Olfr694 by disrupting downstream events that are essential for proper olfactory receptor function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3-kinase inhibitor, which impacts the AKT pathway in olfactory neurons. By inhibiting this pathway, it indirectly affects Olfr694 expression, as the AKT pathway regulates downstream events related to olfactory receptor gene expression. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Pyrvinium Pamoate inhibits Wnt signaling, indirectly affecting Olfr694. By modulating the Wnt pathway, it disrupts the cellular processes necessary for proper olfactory receptor function and gene expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an NF-κB inhibitor that interferes with NF-κB signaling in olfactory neurons. By inhibiting NF-κB, it indirectly suppresses Olfr694, as NF-κB is involved in regulating olfactory receptor function and gene expression. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Bromo-cGMP increases cGMP levels, affecting the cGMP-PKG pathway in olfactory neurons. By modulating this pathway, it indirectly inhibits Olfr694, as it disrupts the downstream events necessary for olfactory receptor activation and signal transduction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3-kinase inhibitor that impacts the PLC-IP3 pathway in olfactory neurons. By inhibiting this pathway, it indirectly influences Olfr694 by disrupting the intracellular signaling processes required for proper olfactory receptor function. | ||||||